MAPT
Maptelligent, Inc.
Set alert
0.00 USD 0.00 0.00%
0.0005 Day range 0.0005
0.0001 52-week range 0.001
- YTD
- +233.33%
- 1 year
- +233.33%
- Open
- 0.0005
- Prev close
- 0.001
- Mkt cap
- 2.50M
- Vol
- 10.00K
- Avg vol
- 5
- EPS
- 0.02
- P/E
- 0.05
More statistics
- Low
- 0.0005
- High
- 0.0005
News
- Arrowhead Pharmaceuticals: ARO-MAPT Results Unlock A New Platform
- Arrowhead Pharmaceuticals Announces ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers
- Arrowhead Pharmaceuticals to Host a Webinar with Interim Clinical Data from a Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer's Disease and Other Tauopathies
- Ionis Partner Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer's Disease
- Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer's Disease and Other Tauopathies
- Arrowhead Pharmaceuticals Requests Regulatory Clearance to Initiate Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer's Disease and Other Tauopathies
- Maptelligent, Inc., is Pleased to Announce it has Entered Into an Agreement With Axim Geospatial
- Maptelligent is Pleased to Announce Its New Strategic Focus, Implementing the Latest in Location Intelligence Making Indoor Maps More Intelligent
- Maptelligent, Inc., is Pleased to Announce a Partnership with Michael Quan with the Interactive Tactical Group
- NSION Technologies & Maptelligent Strategic Partnership
Your note
Sign in to keep a note on MAPT — it syncs with the Stock Master app.